ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976

Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome

February 24, 2012

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

August 10, 2012

Malone Retires As NIH Deputy, Raub To Succeed Him

August 22, 1986

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

In Brief: CCIRC Recommends Central Oncology Group For Phasing Out; Rogers Backs Pay Raise

March 5, 1976